Hematology

Showing folder Hematology

Resources89

Page 2 of 4

Guidelines & protocolsAMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITPAmerican Society of Hematology·Hematology· 2026· 62 pages

1

Clinical notesPERIPROCEDURAL ANTICOAGULATION BLEEDING RISKHematology· 23 pages

Clinical notesPNHBwambale Phenehas·Hematology· 2021· 36 pages

Clinical notesRECESS TERM LECTURE SICKLE CELL ANEMIA 20 1 2021Hematology· 15 pages

Clinical reviewsCOMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAInstitute of Hematology and CREO, University of Perugia, Perugia, Italy·Hematology· 2023· 12 pages

Clinical notesMKSAP 19 BOARDBASICS HEMATOLOGYHematology· 53 pages

1

Guidelines & protocolsAMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITPPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States·Hematology· 2026· 62 pages

1

Clinical notessickle cell anaemia (2)Hematology· 20 pages

Clinical reviewsVEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIESEmma M Groarke, Benjamin Turturice, Bhavisha A Patel, Kaitlin A Quinn, Alice Fike, Peter C Grayson·Hematology· 12 pages

Guidelines & protocolsAMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR SICKLE CELL DISEASE: STEM CELL TRANSPLANTATIONAmerican Society of Hematology·Hematology· 2021· 22 pages

Guidelines & protocolsGUIDELINES FOR THE MANAGEMENT OF EMERGENCIES AND CRITICAL ILLNESS IN PEDIATRIC AND ADULT PATIENTS WITH SICKLE CELL DISEASESpringer Open·Hematology· 34 pages

Guidelines & protocolsAMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR MANAGEMENT OF VENOUS THROMBOEMBOLISM: PREVENTION AND TREATMENT IN PATIENTS WITH CANCERAmerican Society of Hematology·Hematology· 2021· 48 pages

Clinical reviewsIRON DEFICIENCYHealth & Science University·Hematology· 2026· 16 pages

Clinical reviewsMULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENTMayo Clinic·Hematology· 2026· 24 pages

Guidelines & protocolsAMERICAN SOCIETY OF HEMATOLOGY 2023 GUIDELINES FOR MANAGEMENT OF VENOUS THROMBOEMBOLISM: THROMBOPHILIA TESTINGAmerican Society of Hematology·Hematology· 2023· 124 pages

Clinical reviewsANTIDOTES FOR ANTICOAGULATION REVERSALBianca Rocca, M.D., Ph.D., Hugo ten Cate, M.D., Ph.D.·Hematology· 20 pages

Clinical reviewsPOST-TRANSPLANTATION CYCLOPHOSPHAMIDE AND ANTHYMOCTE GLOBULIN IN 8/10 HLA-MISMATCHED UNRELATED DONOR TRANSPLANTATIONIvan Moiseev, Mouad Abouqateb, Christophe Peczynski, Alessandro Busca, Nicolaus Kröger, Raffaella Cerretti, Robert Zeiser, Thomas Schroeder, Matteo Parma, Régis Peffault de Latour, Wolfgang Bethge, Jan Vydra, Didier Blaise, Victoria Panagiota, Franca·Hematology· 2025· 10 pages

Guidelines & protocolsCLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF DISSEMINATED INTRAVASCULAR COAGULATION IN JAPAN 2024. PART 3: SOLID CANCERS AND VASCULAR ABNORMALITIESJapanese Society on Thrombosis and Hemostasis·Hematology· 2024· 11 pages

Clinical reviewsVEXAS SYNDROME IN MYELODYSPLASTIC SYNDROME WITH AUTOIMMUNE DISORDERHuijun Huang, Wenjun Zhang, Wenyu Cai, Jinqin Liu, Huijun Wang, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan, Gang Huang, Robert Peter Gale, Zhijian Xiao·Hematology· 5 pages

Clinical reviewsBLEEDING RISK WITH APIXABAN VS. RIVAROXABAN IN ACUTE VENOUS THROMBOEMBOLISMThe New England Journal of Medicine·Hematology· 2026· 10 pages

Clinical reviewsBLEEDING RISK WITH APIXABAN VS. RIVAROXABAN IN ACUTE VENOUS THROMBOEMBOLISMThe New England Journal of Medicine·Hematology· 2026· 10 pages

Clinical notesVENOUS THROMBOEMBOLISMDaniel M. Witt, Nathan P. Clark, Sara R. Vazquez·Hematology· 9 pages

1

Clinical notesSICKLE CELL DISEASEJin Han, Santosh L. Saraf·Hematology· 5 pages

Clinical notesORAL IRON PRODUCTSKristen M·Hematology· 5 pages

PreviousPage 2 of 4Next